Abstract | BACKGROUND: Racial disparities in cancer outcomes are increasingly recognized, but comprehensive analyses, including molecular studies, are limited. The objective of the current study was to perform a pan- cancer clinical and epigenetic molecular analysis of outcomes in African American (AA) and European American (EA) patients. METHODS: Cross-platform analyses using cancer databases (the Surveillance, Epidemiology, and End Results program database and the National Cancer Data Base) and a molecular database (The Cancer Genome Ancestry Atlas) were performed to evaluate clinical and epigenetic molecular differences between AA and EA patients based on genetic ancestry. RESULTS: In the primary pan- cancer survival analysis using the Surveillance, Epidemiology, and End Results database (2,045,839 patients; 87.5% EA and 12.5% AA), AA patients had higher mortality rates for 28 of 42 cancer types analyzed (hazard ratio, >1.0). AAs continued to have higher mortality in 13 cancer types after adjustment for socioeconomic variables using the National Cancer Database (5,150,023 patients; 11.6% AA and 88.4% EA). Then, molecular features of 5,283 tumors were analyzed in patients who had genetic ancestry data available (87.2% EA and 12.8% AA). Genes were identified with altered DNA methylation along with increased microRNA expression levels unique to AA patients that are associated with cancer drug resistance. Increased miRNAs (miR-15a, miR-17, miR-130-3p, miR-181a) were noted in common among AAs with breast, kidney, thyroid, or prostate carcinomas. CONCLUSIONS: The current results identified epigenetic features in AA patients who have cancer that may contribute to higher mortality rates compared with EA patients who have cancer. Therefore, a focus on molecular signatures unique to AAs may identify actionable molecular abnormalities.
|
Authors | Olivia D Lara, Ying Wang, Amma Asare, Tao Xu, Hua-Sheng Chiu, Yuexin Liu, Wei Hu, Pavel Sumazin, Shitanshu Uppal, Lin Zhang, J Alejandro Rauh-Hain, Anil K Sood |
Journal | Cancer
(Cancer)
Vol. 126
Issue 4
Pg. 800-807
(02 15 2020)
ISSN: 1097-0142 [Electronic] United States |
PMID | 31730714
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2019 American Cancer Society. |
Chemical References |
|
Topics |
- Black or African American
(genetics, statistics & numerical data)
- Aged
- Epigenesis, Genetic
(genetics)
- Female
- Health Status Disparities
- Humans
- Incidence
- Male
- MicroRNAs
(genetics)
- Middle Aged
- Neoplasms
(epidemiology, ethnology, genetics)
- SEER Program
(statistics & numerical data)
- Survival Analysis
- United States
(epidemiology)
- White People
(genetics, statistics & numerical data)
|